<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00849979</url>
  </required_header>
  <id_info>
    <org_study_id>2007-0228</org_study_id>
    <nct_id>NCT00849979</nct_id>
  </id_info>
  <brief_title>Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy</brief_title>
  <official_title>M.D. Anderson Symptom Inventory (MDASI-GI) Validation and Clinical Utility in Patients With Gastrointestinal Cancers Being Treated or Followed by GI Medical Oncology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to learn more about the symptoms that may occur in patients with GI&#xD;
      cancer. The types of GI cancer being studied are cancers of the stomach, liver, pancreas,&#xD;
      colon, and rectum. Researchers want to test a newly-designed questionnaire called the M. D.&#xD;
      Anderson Symptom Inventory - Gastrointestinal (MDASI-GI) questionnaire.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Questionnaires:&#xD;
&#xD;
      If you agree to take part in this study, you will be asked to complete the MDASI-GI&#xD;
      questionnaire on Day 1. It asks about any symptoms you may be experiencing, and how those&#xD;
      symptoms may be interfering with your daily life. You will also complete two questionnaires&#xD;
      that ask about the overall quality of your life. In total, these questionnaires should take&#xD;
      about 20 minutes to complete.&#xD;
&#xD;
      You will then complete a questionnaire that asks for demographic information such as your age&#xD;
      and marital status. It should take about 5 minutes.&#xD;
&#xD;
      You will receive another copy of the MDAS-GI questionnaire and the quality-of-life&#xD;
      questionnaire to take home and complete 1 week later. The research staff will call you to&#xD;
      remind you when it is time to complete this questionnaires. You should mail it back to the&#xD;
      study staff in a stamped, pre-addressed envelope that will be provided to you.&#xD;
&#xD;
      Evaluation of Questionnaires:&#xD;
&#xD;
      Also on Day 1, a small group of participants (25 out of the 185 total participants) will&#xD;
      complete an additional questionnaire called a &quot;cognitive debriefing&quot; questionnaire. These 25&#xD;
      participants will be the first 5 participants to join this study who have 1 of the 5 types of&#xD;
      cancer being studied.&#xD;
&#xD;
      The questionnaire asks questions related to how easy it was for you to answer the questions&#xD;
      on the MDASI-GI questionnaire, whether the questions relate to the symptoms you may be&#xD;
      experiencing, and whether any other questions should be added. This questionnaire should take&#xD;
      about 10 minutes to complete.&#xD;
&#xD;
      Interview:&#xD;
&#xD;
      Another small group of participants (a different 25 out of the 185 total) will have a&#xD;
      one-on-one interview with a member of the study staff. During the interview, you will be&#xD;
      asked to further describe the symptoms you may have experienced. This interview will be&#xD;
      scheduled for a day when you are going to be at M. D. Anderson for a routine clinic visit. It&#xD;
      should take about 30 minutes to complete.&#xD;
&#xD;
      You and the interviewer will be the only ones in the room during the interview, and the&#xD;
      information collected will be kept confidential. The interview will be tape-recorded.&#xD;
&#xD;
      Questionnaire and Interview Content:&#xD;
&#xD;
      Your responses will not be shared with your doctor. If you feel you need a doctor's opinion&#xD;
      about anything that is asked about, please contact your doctor.&#xD;
&#xD;
      Information Collection:&#xD;
&#xD;
      As part of this research study, the research staff will collect information from your medical&#xD;
      record one time. This will include data about the cancer, cancer treatment, and routine test&#xD;
      results.&#xD;
&#xD;
      Length of Study Participation:&#xD;
&#xD;
      After you mail back the questionnaire at Week 1 (or complete it by phone interview with&#xD;
      research staff), or after the interview if you have one, your active participation in this&#xD;
      study will be over.&#xD;
&#xD;
      This is an investigational study. Up to 185 patients will take part in this study. All will&#xD;
      be enrolled at M. D. Anderson.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of M. D. Anderson Symptom Inventory - Gastrointestinal (MDASI-GI) Questionnaire (Response)</measure>
    <time_frame>2 Years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">184</enrollment>
  <condition>Gastrointestinal Cancer</condition>
  <arm_group>
    <arm_group_label>Questionnaire</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Questionnaire + Interview</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>Day 1 MDASI-GI Questionnaire</description>
    <arm_group_label>Questionnaire</arm_group_label>
    <arm_group_label>Questionnaire + Interview</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interview</intervention_name>
    <description>Open-ended, audiotaped interviews</description>
    <arm_group_label>Questionnaire + Interview</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients must be out-patients being reviewed or treated in M. D. Anderson's Department&#xD;
             of GI Medical Oncology.&#xD;
&#xD;
          -  Patients will have received a confirmed pathological diagnosis of GI cancer (gastric&#xD;
             cancer, liver cancer, pancreatic cancer, colorectal cancer).&#xD;
&#xD;
          -  Patients will or will not be undergoing chemotherapy or treatment with other agents on&#xD;
             the day of enrollment.&#xD;
&#xD;
          -  Patients must be &gt; or = 18 years of age.&#xD;
&#xD;
          -  Patients must be able to speak and read English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who, in research staff's estimation, cannot understand the intent of the&#xD;
             study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xin Shelley Wang, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT MD Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UT MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>MD Anderson Cancer Center website</description>
  </link>
  <verification_date>July 2012</verification_date>
  <study_first_submitted>February 23, 2009</study_first_submitted>
  <study_first_submitted_qc>February 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2009</study_first_posted>
  <last_update_submitted>July 26, 2012</last_update_submitted>
  <last_update_submitted_qc>July 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal</keyword>
  <keyword>Gastric</keyword>
  <keyword>Gastrointestinal</keyword>
  <keyword>GI</keyword>
  <keyword>Liver</keyword>
  <keyword>Pancreas</keyword>
  <keyword>Gastrointestinal Cancers</keyword>
  <keyword>Gastro-Intestinal Chemotherapy</keyword>
  <keyword>M.D. Anderson Symptom Inventory</keyword>
  <keyword>MDASI-GI</keyword>
  <keyword>Medical Oncology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

